Richard I Eisenstadt Insider Trading $NEOS Neos Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Richard I Eisenstadt.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Richard I Eisenstadt. Richard I Eisenstadt is VP, Finance & C.F.O. in Ocera Therapeutics, Inc. ($TZYM) and Chief Financial Officer in AYTU BIOPHARMA, INC ($AYTU) and Chief Financial Officer in Neos Therapeutics, Inc. ($NEOS).

Richard I Eisenstadt in Neos Therapeutics, Inc.

Trading Symbol: NEOS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Eisenstadt: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2021
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Richard I Eisenstadt in Neos Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AYTU, NEOS, TZYM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD1.49115,000171,3500
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD2.31230,276531,9380
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD8.3056,250466,8750
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD7.0045,000315,0000
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD10.7450,000537,0000
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD25.5060,2301,535,8650
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD9.3212,500116,5000
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseD2.9186,167250,7460
Mar 19 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...SellD0.00126,24500126.2 K to 0 (-100.00 %)
Mar 16 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Payment of ExerciseF0.8414,82512,512126,245141.1 K to 126.2 K (-10.51 %)
Mar 16 2021NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Payment of ExerciseF0.881,3901,227141,070142.5 K to 141.1 K (-0.98 %)
Mar 04 2020NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA1.49115,000171,350115,000
Mar 04 2020NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...GrantA0.00100,00000-100,000 to 0 (-100.00 %)
Mar 04 2019NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA2.31230,276531,938230,276
Dec 13 2018NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...BuyP2.165,00010,82042,46037.5 K to 42.5 K (+13.35 %)
Mar 05 2018NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA8.3056,250466,87556,250
Mar 05 2018NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...GrantA0.0018,750037,46018.7 K to 37.5 K (+100.21 %)
May 02 2017NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA7.0045,000315,00045,000
May 02 2017NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...GrantA0.0015,000018,7103.7 K to 18.7 K (+404.31 %)
Aug 25 2016NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...BuyP6.823,71025,2843,7100 to 3.7 K
Apr 01 2016NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA10.7450,000537,00050,000
Sep 03 2015NEOSNeos Therapeutics, ...Eisenstadt Richard IChief Financial Off ...Option ExerciseA25.5060,2301,535,86560,230

Page:   1